Skip to main content

Is the cannabis gold rush over? Moves by Curaleaf, Ayr, Akerna and other companies point to tough times.

Ayr scraps $55 million Chicago deal, Curaleaf cuts staff, Organigram receives delisting notice and Akerna moves out of the pot business altogether.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.